Methylphenidate improves prefrontal cortical cognitive function through α2 adrenoceptor and dopamine D1 receptor actions: Relevance to therapeutic effects in Attention Deficit Hyperactivity Disorder

BACKGROUND: Methylphenidate (MPH) is the classic treatment for Attention Deficit Hyperactivity Disorder (ADHD), yet the mechanisms underlying its therapeutic actions remain unclear. Recent studies have identified an oral, MPH dose regimen which when given to rats produces drug plasma levels similar...

Descripción completa

Detalles Bibliográficos
Autores principales: Arnsten, Amy FT, Dudley, Anne G
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2005
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1143775/
https://www.ncbi.nlm.nih.gov/pubmed/15916700
http://dx.doi.org/10.1186/1744-9081-1-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1143775/
https://www.ncbi.nlm.nih.gov/pubmed/15916700
http://dx.doi.org/10.1186/1744-9081-1-2

Ejemplares similares